Wellington Management Group LLP 13D and 13G filings for Zentalis Pharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-02-09 08:40 am Sale |
2023-12-29 | 13G | Zentalis Pharmaceuticals, Inc. ZNTL |
Wellington Management Group LLP | 68,791 0.100% |
-3,549,702 (-98.10%) |
Filing |
| 2023-02-06 2:59 pm Purchase |
2022-12-30 | 13G | Zentalis Pharmaceuticals, Inc. ZNTL |
Wellington Management Group LLP | 3,618,493 6.340% |
3,618,493 (New Position) |
Filing |